Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Heart Protein TSLP Reduces Post-Heart Attack Damage by Recruiting Protective Immune CellsLongevity & Aging

Heart Protein TSLP Reduces Post-Heart Attack Damage by Recruiting Protective Immune Cells

Researchers discovered that thymic stromal lymphopoietin (TSLP), a protein released by heart muscle cells after myocardial infarction, plays a crucial protective role in cardiac recovery. Using mouse models, they found that TSLP recruits beneficial immune cells called eosinophils to the heart, which help resolve inflammation and prevent excessive scarring. When TSLP was absent, mice experienced worse heart damage and more fibrosis. The protein works by blocking harmful cellular death pathways and promoting healing, suggesting TSLP-based therapies could improve outcomes for heart attack patients.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.